← National Association of Chain Drug Stores
FDANonrulemakingFDA-2017-D-2497

FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids

RIN
—
Last modified
Jan 29, 2018
Comment window
closed 3305d ago
National Association of Chain Drug Stores filings
1

Activity

National Association of Chain Drug Stores filed 1 comment on this docket between Jul 13, 2017 and Jul 13, 2017. 20 other organizations filed here. The comment window closed 3305d ago.

What National Association of Chain Drug Stores filed (1)

Jul 13, 2017· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2017-D-2497-0607

The National Association of Chain Drug Stores appreciates the opportunity to comment to FDA on the draft revisions to the FDA Blueprint for Prescriber Education on Extended-Release and Long-Acting (ER/LA) Opioids. We thank the agency for considering our views on this matter.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (20)

See everyone who commented →
FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids (FDA) — National Association of Chain Drug Stores | OpenPolis